The Assessment of Acne Vulgaris--the Leeds Technique

Overview

Journal Br J Dermatol

Publisher Oxford University Press

Specialty Dermatology

Date 1984 Jul 1

PMID 6234917

Citations 39

Authors

B M Burke

W J Cunliffe

Affiliations

Soon will be listed here.

Abstract

We describe two simple, reproducible scoring systems for assessing acne severity, and we emphasize the technical problems which could invalidate either technique. Constant baseline data is desirable for any clinical trial, and our data clearly show that acne patients should ideally be off all treatment for at least 2 months before the start of a therapeutic trial.

Citing Articles

Oral and topical spironolactone in acne treatment: A meta-analysis of effectiveness and safety.

AlEdani E, Abo Zeid M, Khalefa K, Abbas A, Aboali A, Raslan H Naunyn Schmiedebergs Arch Pharmacol. 2025; .

PMID: 39878821 DOI: 10.1007/s00210-025-03840-6.

Deciphering the Role of Androgen in the Dermatologic Manifestations of Polycystic Ovary Syndrome Patients: A State-of-the-Art Review.

Taieb A, Feryel A Diagnostics (Basel). 2024; 14(22).

PMID: 39594244 PMC: 11592971. DOI: 10.3390/diagnostics14222578.

Prevalence, Phenotypes, and Comorbidities of Polycystic Ovary Syndrome Among Indian Women.

Ganie M, Chowdhury S, Malhotra N, Sahay R, Bhattacharya P, Agrawal S JAMA Netw Open. 2024; 7(10):e2440583.

PMID: 39441596 PMC: 11581580. DOI: 10.1001/jamanetworkopen.2024.40583.

A Comprehensive Review of the Acne Grading Scale in 2023.

Bae I, Kwak J, Na C, Kim M, Shin B, Choi H Ann Dermatol. 2024; 36(2):65-73.

PMID: 38576244 PMC: 10995619. DOI: 10.5021/ad.23.094.

SPIOMET4HEALTH-efficacy, tolerability and safety of lifestyle intervention plus a fixed dose combination of spironolactone, pioglitazone and metformin (SPIOMET) for adolescent girls and young women with polycystic ovary syndrome: study protocol for....

Garcia-Beltran C, Malpique R, Andersen M, Bas F, Bassols J, Darendeliler F Trials. 2023; 24(1):589.

PMID: 37715279 PMC: 10503102. DOI: 10.1186/s13063-023-07593-6.